{
    "clinical_study": {
        "@rank": "11414", 
        "arm_group": {
            "arm_group_label": "Rocuronium", 
            "arm_group_type": "Experimental", 
            "description": "Intravenous infusion of rocuronium with the goal of TOF 0.70 and >0.90"
        }, 
        "brief_summary": {
            "textblock": "This study describe the effect of partial neuromuscular blockade of rocuronium on the acute\n      hypoxic ventilatory response in patients with OSA before and after 3 month of CPAP\n      treatment."
        }, 
        "brief_title": "Effect of Rocuronium on the Acute Hypoxic Ventilatory Response in Patients With Obstructive Sleep Apnea", 
        "completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "OSA", 
            "Rocuronium", 
            "Neuromuscular Blockade", 
            "Hypoxic Ventilatory Response", 
            "CPAP"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Sleep Apnea Syndromes", 
                "Sleep Apnea, Obstructive"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male with diagnosed moderate OSA (AHI 15-30), untreated, but planned for CPAP\n             treatment. Healthy except for OSA and well controlled tablet treated hypertension\n             where the treatment has not been changed during the last 3 month. None smokers. 18-70\n             years old. BMI <35.\n\n        Exclusion Criteria:\n\n          -  If they don\u00b4t fit the inclusion criteria"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 1, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01672606", 
            "org_study_id": "OSA ROC"
        }, 
        "intervention": {
            "arm_group_label": "Rocuronium", 
            "description": "Partial neuromuscular blockade with rocuronium with a TOF 0.70", 
            "intervention_name": "Rocuronium", 
            "intervention_type": "Drug", 
            "other_name": "CPAP"
        }, 
        "intervention_browse": {
            "mesh_term": "Rocuronium"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 2, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Stockholm", 
                    "country": "Sweden", 
                    "zip": "se-17176"
                }, 
                "name": "Department of Anesthesiology, Surgical Sciences and Intensive Care Medicine, Karolinska University Hospital"
            }
        }, 
        "location_countries": {
            "country": "Sweden"
        }, 
        "number_of_arms": "1", 
        "official_title": "Effect of Partial Neuromuscular Blockade by Rocuronium on the Acute Hypoxic Ventilatory Response in Patients With Obstructive Sleep Apnea-before and After Three Month CPAP Treatment. A Non-randomized, Non-blinded Study.", 
        "overall_official": {
            "affiliation": "Karolinska University Hospital and Karolinska Institutet", 
            "last_name": "Malin Jonsson Fagerlund, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "Sweden: Medical Products Agency", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Hypoxic ventilatory response", 
            "safety_issue": "Yes", 
            "time_frame": "At baseline, with CPAP, at TOF 0.70 and at TOF >0.90. At diagnosis and after 3 month of CPAP treatment at home"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01672606"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Karolinska University Hospital", 
            "investigator_full_name": "Malin Jonsson Fagerlund", 
            "investigator_title": "MD, PhD", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Hypercarbic ventilatory response", 
                "safety_issue": "Yes", 
                "time_frame": "At baseline, with CPAP, at TOF 0.70 and at TOF >0.90. At diagnosis and after 3 month of CPAP treatment at home"
            }, 
            {
                "measure": "Hypoxic ventilatory response", 
                "safety_issue": "Yes", 
                "time_frame": "At diagnosis and after 3 month of CPAP treatment at home"
            }, 
            {
                "measure": "Hypoxic ventilatory response during acute CPAP treatment", 
                "safety_issue": "Yes", 
                "time_frame": "At diagnosis and after 3 month of CPAP treatment"
            }, 
            {
                "measure": "Hypercarbic ventilatory response", 
                "safety_issue": "Yes", 
                "time_frame": "At diagnosis and after 3 month of CPAP treatment at home"
            }, 
            {
                "measure": "Hypercarbic ventilatory response during acute CPAP treatment", 
                "safety_issue": "Yes", 
                "time_frame": "At diagnosis and after 3 month CPAP treatment at home"
            }, 
            {
                "measure": "Upper airway obstruction", 
                "safety_issue": "Yes", 
                "time_frame": "At TOF 0.70 and TOF >0.90. At diagnosis and after 3 month CPAP treatment."
            }
        ], 
        "source": "Karolinska University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Malin Jonsson Fagerlund", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2012", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}